hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axis

22:17 EDT 15 Jun 2018 | Nature Publishing

More From BioPortfolio on "hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axis"